What is a sputum routine microscopy (SRM) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sputum Routine Microscopy Test

Sputum routine microscopy (SRM) is a laboratory test that involves microscopic examination of a Gram-stained sputum sample to identify bacterial pathogens causing lower respiratory tract infections, primarily used to guide initial antibiotic selection in pneumonia. 1

What the Test Involves

Specimen Collection and Processing

  • A deep-cough specimen must be obtained before antibiotic therapy is initiated, then rapidly transported and processed in the laboratory within a few hours of collection 1
  • The specimen should be mucopurulent material selected by gross inspection, representing true lower respiratory tract secretions rather than saliva 2
  • In office practice, a slide may be prepared, air-dried, and heat-fixed for subsequent interpretation even if immediate Gram staining is not feasible 1

Quality Screening (Cytological Criteria)

The specimen must meet strict cytological criteria to be considered valid for interpretation:

  • ≥25 polymorphonuclear cells (PMN) AND <10 squamous epithelial cells (SEC) per low-power field (100x magnification) 1, 3
  • Some authorities use a criterion of >10 WBC per SEC 1
  • Invalid specimens (≥10 squamous epithelial cells and ≤25 polymorphonuclear cells per field) should be rejected and not examined further, as they represent upper airway contamination rather than lower respiratory secretions 1, 3
  • Only 39-41% of pneumonia patients can produce adequate quality specimens by these criteria 1, 3

Microscopic Examination

  • Gram staining is performed on specimens meeting cytological criteria, examining for the relative number and types of bacteria present 1
  • The test looks for a predominant bacterial morphotype (≥90% of organisms), which significantly increases diagnostic accuracy 1, 3
  • Lancet-shaped gram-positive diplococci suggest Streptococcus pneumoniae, the most common cause of community-acquired pneumonia 1
  • The first 100 microscopic fields are typically examined, as 99.6% of positive findings are detected within this range 4

Diagnostic Performance

Sensitivity and Specificity

  • For pneumococcal pneumonia, sensitivity is 50-60% and specificity is >80% when a predominant morphotype is identified 1
  • When good-quality sputum shows a single or preponderant morphotype, sensitivity for S. pneumoniae is 35.4% with specificity of 96.7% 1, 3
  • For Haemophilus influenzae, sensitivity is 42.8% with specificity of 99.4% 1, 3
  • In one prospective study, Gram stain predicted the blood culture isolate in 85% of valid specimens, allowing appropriate antibiotic selection in >90% of patients 1

Clinical Utility

The test is recommended for hospitalized patients with community-acquired pneumonia to guide initial antimicrobial therapy selection, provided specimens are obtained before antibiotics and properly processed 1

  • The test is particularly reliable for Haemophilus pneumonia due to profuse organism numbers 1
  • Finding many WBCs with no bacteria reliably excludes infection by most ordinary bacterial pathogens in patients not yet on antibiotics 1
  • Results are usually available within hours, unlike culture which takes 24-48 hours 1

Important Limitations and Pitfalls

Technical Limitations

  • The validity of Gram stain interpretation is directly related to the experience of the observer, with potential interobserver variability 1
  • Laboratory quality control is essential due to variability in interpretation between technicians 1, 3
  • Many pneumonia patients cannot produce sputum, particularly older patients 1, 3

Pathogen-Specific Exceptions

  • Mycobacteria and Legionella species are exceptions where microscopic criteria may yield misleading results and should not be evaluated using standard cytological screening 1
  • Atypical pathogens (Mycoplasma, Chlamydophila) cannot be visualized on routine Gram stain 3

Pre-analytical Factors

  • Prior antibiotic administration significantly reduces diagnostic yield of both Gram stain and culture 1, 3
  • Delays in processing the specimen compromise results 1
  • Even with bacteremic pneumococcal pneumonia, sputum cultures are positive in only 40-50% of cases using standard techniques 1, 3

Complementary Testing

  • Routine sputum microscopy should be accompanied by aerobic culture of specimens meeting cytological criteria, with semi-quantitative results reported 1
  • Blood cultures should also be obtained from hospitalized patients 1
  • For severe disease, urinary antigen tests for S. pneumoniae and Legionella pneumophila should be added where available 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Sputum analysis and culture.

Annals of emergency medicine, 1986

Guideline

Criteria for Adequate Sputum Gram Stain and Culture

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Optimal tuberculosis case detection by direct sputum smear microscopy: how much better is more?

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.